Our genetically engineered, iPSC-derived cell products are designed to specifically target hematologic and solid tumor cancers, with a broadening application to autoimmune diseases. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of cancer and autoimmune disease care.
Please note Century Therapeutics does not solicit prospective Colleagues directly via Telegram (or other social media sites), or require potential candidates to make purchases of goods or services.
Company Details
- Employees
- 157
- Founded
- -
- Address
- 25 N 38th St, 11th Floor,united States
- Industry
- Biotechnology
- Website
- centurytx.com
- Keywords
- in cellular reprogramming.
- HQ
- Philadelphia, Pennsylvania
Century Therapeutics, Inc Questions
Century Therapeutics, Inc's website is centurytx.com
Century Therapeutics, Inc's LinkedIn profile is https://www.linkedin.com/company/centurytx
Century Therapeutics, Inc has
157 employees.
View email and phone details for 157
employees at Century Therapeutics, Inc.
Century Therapeutics, Inc's industry is
Biotechnology
Century Therapeutics, Inc's top competitors are
Cabaletta Bio,
Vertex Pharmaceuticals,
Passage Bio,
Interius Biotherapeutics,
Legend Biotech,
Spark Therapeutics, Inc.,
Swanbio Therapeutics,
Clade Therapeutics,
Carisma Therapeutics,
Verismo Therapeutics.
Century Therapeutics, Inc's categories are Biotechnology
Century Therapeutics, Inc's founding year is 2018
